Related Experiment Video
Updated: Apr 17, 2026

Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression
Published on: March 5, 2013
miR-503 represses human cell proliferation and directly targets the oncogene DDHD2 by non-canonical target pairing
Damon Polioudakis1, Nathan S Abell2, Vishwanath R Iyer3
1Department of Molecular Biosciences, Center for Systems and Synthetic Biology, Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas, USA. damon.polioudakis@gmail.com.
Background:
The pathways regulating the transition of mammalian cells from quiescence to proliferation are mediated by multiple miRNAs. Despite significant improvements in our understanding of miRNA targeting, the majority of miRNA regulatory networks are still largely unknown and require experimental validation.
Results:
Here we identified miR-503, miR-103, and miR-494 as negative regulators of proliferation in primary human cells. We experimentally determined their genome wide target profiles using RNA-induced silencing complex (RISC) immunoprecipitations and gene expression profiling. Analysis of the genome wide target profiles revealed evidence of extensive regulation of gene expression through non-canonical target pairing by miR-503. We identified the proto-oncogene DDHD2 as a target of miR-503 that requires pairing outside of the canonical 5' seed region of miR-503, representing a novel mode of miRNA-target pairing. Further bioinformatics analysis implicated miR-503 and DDHD2 in breast cancer tumorigenesis.
Conclusions:
Our results provide an extensive genome wide set of targets for miR-503, miR-103, and miR-494, and suggest that miR-503 may act as a tumor suppressor in breast cancer by its direct non-canonical targeting of DDHD2.
Insights
MicroRNAs (miRNAs) regulate cell proliferation. Researchers identified miR-503, miR-103, and miR-494 as negative regulators, with miR-503 potentially suppressing breast cancer by targeting DDHD2.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Cellular quiescence to proliferation transitions involve multiple microRNAs (miRNAs).
- Understanding miRNA regulatory networks remains incomplete, necessitating experimental validation.
Purpose of the Study:
- Identify novel miRNA regulators of primary human cell proliferation.
- Characterize genome-wide miRNA target profiles and regulatory mechanisms.
- Investigate the role of miR-503 and its targets in breast cancer.
Main Methods:
- RNA-induced silencing complex (RISC) immunoprecipitation.
- Gene expression profiling.
- Bioinformatics analysis of miRNA-target interactions.
Main Results:
- miR-503, miR-103, and miR-494 identified as negative regulators of proliferation.
- Genome-wide target profiling revealed extensive non-canonical miRNA targeting by miR-503.
- DDHD2 identified as a novel non-canonical miR-503 target, implicated in breast cancer.
Conclusions:
- Provided extensive genome-wide targets for miR-503, miR-103, and miR-494.
- miR-503 acts as a tumor suppressor in breast cancer via non-canonical DDHD2 targeting.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Negative Regulator Molecules
Induced Pluripotent Stem Cells
Somatic...
Mitogens and the Cell Cycle

